HUM:NYE-Humana Inc (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 263.2

Change

-1.20 (-0.45)%

Market Cap

N/A

Volume

1.72M

Analyst Target

USD 448.08
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-28 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

+1.36 (+0.32%)

USD 415.38B
ELV Elevance Health Inc

-7.86 (-1.86%)

USD 99.57B
CNC Centene Corp

+1.78 (+3.09%)

USD 30.11B
MOH Molina Healthcare Inc

+5.69 (+1.81%)

USD 17.62B
OSCR Oscar Health Inc

+0.39 (+3.19%)

USD 3.26B
NEUE NeueHealth Inc

-0.16 (-2.35%)

USD 0.05B
CI Cigna Corp

-0.54 (-0.16%)

N/A
CVS CVS Health Corp

-0.39 (-0.60%)

N/A

ETFs Containing HUM

MVFD Northern Lights Fund Trus.. 3.19 % 0.00 %

+0.17 (+0.70%)

USD 0.06B
TUSB:CA TD Select U.S. Short Term.. 2.16 % 0.28 %

-0.01 (0.70%)

CAD 0.02B
TUSB-U:CA TD Select U.S. Short Term.. 2.16 % 0.00 %

+0.02 (+0.70%)

CAD 8.25M
SRHQ Elevation Series Trust - .. 1.84 % 0.00 %

+0.08 (+0.70%)

N/A
RSPH Invesco S&P 500 Equal Wei.. 1.80 % 0.00 %

+0.12 (+0.70%)

USD 0.80B
RSPE Invesco Exchange-Traded F.. 0.70 % 0.00 %

+0.07 (+0.70%)

USD 0.03B
CVMC Morgan Stanley ETF Trust .. 0.50 % 0.00 %

+0.23 (+0.70%)

N/A
EUSA iShares MSCI USA Equal We.. 0.00 % 0.15 %

+0.17 (+0.70%)

USD 1.29B
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.09 (+0.70%)

N/A
MUS:CA 0.00 % 0.58 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

+0.66 (+0.70%)

N/A
VETS 0.00 % 0.60 %

N/A

N/A
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

+0.46 (+0.70%)

USD 0.09B
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.74% 56% F 81% B-
Dividend Return 0.35% 20% F 14% F
Total Return 4.09% 56% F 81% B-
Trailing 12 Months  
Capital Gain -13.18% 56% F 21% F
Dividend Return 1.46% 40% F 29% F
Total Return -11.72% 56% F 21% F
Trailing 5 Years  
Capital Gain -30.26% 17% F 13% F
Dividend Return 4.42% 25% F 9% A-
Total Return -25.84% 17% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain -4.40% 11% F 16% F
Dividend Return -3.68% 11% F 11% F
Total Return 0.72% 40% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 20.61% 78% C+ 49% F
Risk Adjusted Return -17.87% 11% F 13% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector